Development Level

Tbio 7 | 11,445
Tclin 6 | 613
Tchem 2 | 1,598

IMPC Phenotype

abnormal behavior 1 | 298
abnormal eye anterior chamber ... 1 | 9
increased mean corpuscular vol... 1 | 92
preweaning lethality, incomple... 1 | 499

Disease

Cancer 12 | 2,499
ovarian cancer 11 | 8,520
Breast cancer 10 | 3,578
Carcinoma 10 | 11,493
lung cancer 10 | 4,740
psoriasis 10 | 6,694
Schizophrenia 9 | 1,160
cystic fibrosis 9 | 1,696
glioblastoma 9 | 5,792
intraductal papillary-mucinous adenoma (IPMA) 9 | 2,955
intraductal papillary-mucinous neoplasm (IPMN) 9 | 3,291
malignant mesothelioma 9 | 3,232
medulloblastoma, large-cell 9 | 6,241
osteosarcoma 9 | 7,950
lung adenocarcinoma 8 | 2,716
atypical teratoid / rhabdoid tumor 7 | 5,112
pituitary cancer 7 | 1,972
Prostatic Neoplasms 6 | 495
adult high grade glioma 6 | 3,801
colon cancer 6 | 1,478
ependymoma 6 | 4,679
interstitial cystitis 6 | 2,312
non-small cell lung cancer 6 | 2,890
tuberculosis 6 | 2,010
Adenocarcinoma 5 | 122
Breast Neoplasms 5 | 445
Depressive disorder 5 | 409
Endometriosis 5 | 540
Mammary Neoplasms 5 | 425
Rheumatoid arthritis 5 | 1,191
cutaneous lupus erythematosus 5 | 1,057
group 3 medulloblastoma 5 | 4,104
intraductal papillary-mucinous carcinoma (IPMC) 5 | 2,989
invasive ductal carcinoma 5 | 2,951
lung carcinoma 5 | 2,843
pancreatic cancer 5 | 2,398
primitive neuroectodermal tumor 5 | 3,035
ulcerative colitis 5 | 1,819
Anemia 4 | 365
Autosomal recessive predisposition 4 | 1,442
Bipolar Disorder 4 | 666
Carcinoma, Hepatocellular 4 | 228
Kidney cancer 4 | 2,613
Liver Cirrhosis, Experimental 4 | 769
Liver carcinoma 4 | 240
Major Depressive Disorder 4 | 301
Mental Depression 4 | 333
Mood Disorders 4 | 184
Osteoporosis 4 | 363
astrocytoma 4 | 1,146
breast carcinoma 4 | 1,638
diabetes mellitus 4 | 1,728
ductal carcinoma in situ 4 | 1,745
hepatocellular carcinoma 4 | 547
oligodendroglioma 4 | 2,850
Adenoma 3 | 167
Alcoholic Intoxication, Chronic 3 | 289
Arthritis 3 | 290
Astrocytoma, Pilocytic 3 | 3,081
Bone pain 3 | 42
Carcinoma, Squamous Cell 3 | 110
Cell Transformation, Neoplastic 3 | 97
Chronic Lymphocytic Leukemia 3 | 262
Endometrial cancer 3 | 311
Gastrointestinal system disease 3 | 54
Hemoglobin low 3 | 124
Leukemia 3 | 104
Lung Neoplasms 3 | 232
Mammary Neoplasms, Experimental 3 | 154
Myocardial Ischemia 3 | 169
Neoplasm Metastasis 3 | 168
Neoplasm Recurrence, Local 3 | 37
Neoplastic Cell Transformation 3 | 89
Neurodegenerative disease 3 | 414
Osteonecrosis 3 | 27
Polycystic ovary syndrome 3 | 360
Precancerous Conditions 3 | 80
Squamous cell carcinoma 3 | 129
Synovitis 3 | 78
Unipolar Depression 3 | 250
Vascular disease 3 | 319
acute quadriplegic myopathy 3 | 1,158
adrenocortical carcinoma 3 | 1,428
chronic rhinosinusitis 3 | 512
mucosa-associated lymphoid tissue lymphoma 3 | 484
nasopharyngeal carcinoma 3 | 1,058
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
posterior fossa group A ependymoma 3 | 468
primary pancreatic ductal adenocarcinoma 3 | 1,109
Atherosclerosis 2 | 291
Coronary artery disease 2 | 268
Disease Progression 2 | 136
Heart disease 2 | 306
Hypertension 2 | 396
Kidney disease 2 | 430
Menopausal flushing 2 | 17
Postmenopausal osteoporosis 2 | 19
Stomach Neoplasms 2 | 300
head and neck cancer 2 | 271
medulloblastoma 2 | 720

Tissue

Blood and immune system 15 | 16,909
Digestive Tract 15 | 17,369
Endocrine System 15 | 18,159
Female tissues 15 | 17,400
Liver and Pancreas 15 | 16,750
Male tissues 15 | 17,142
Respiratory system 15 | 16,393
Skin and soft tissues 15 | 17,230
Urinary Tract 15 | 16,678
Nervous System 14 | 16,725
Cardiovascular System 13 | 15,192

Target Family

Non-IDG 8 | 12,091
Kinase 2 | 634
Nuclear Receptor 2 | 48
Transcription Factor 2 | 1,400
Enzyme 1 | 4,145

GO Process

mammary gland alveolus develop... 15 | 15
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Tumor necrosis factor receptor superfamily member 11A TNFRSF11A Tbio Non-IDG -3.26478 1689.0 464
Epithelial discoidin domain-containing receptor 1 DDR1 Tchem Kinase -2.26801 0.00000 534
Homeobox protein Hox-A5 HOXA5 Tbio Transcription Factor -2.07535 127.1 369
Receptor tyrosine-protein kinase erbB-4 ERBB4 Tclin Kinase -2.78704 558.2 1072
Androgen receptor AR Tclin Nuclear Receptor -3.82874 7137.7 1609
Pro-epidermal growth factor EGF Tbio Non-IDG -3.75933 4903.2 978
Tryptophan 5-hydroxylase 1 TPH1 Tclin Enzyme -2.93036 772.3 415
Prohibitin-2 PHB2 Tbio Non-IDG -2.95347 911.7 370
Estrogen receptor ESR1 Tclin Nuclear Receptor -4.00480 8421.6 2610
Amphiregulin AREG Tbio Non-IDG -2.59721 307.5 389